CPH 0.00% 0.9¢ creso pharma limited

Ann: Creso Pharma completes US OTC dual listing, page-95

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 524 Posts.
    lightbulb Created with Sketch. 61
    bit of a noob question regarding the dual listing.

    lots of posters on here seem to think because the other listing gained on its first trade day, we should also go higher. doesnt opening a dual listing also offer a dilution factor? just because we opened a second listing it doesnt suddenly make the company worth more does it?

    ive been thinking of it like this:

    the asx only listing has been a whole cake (the cake is CPH) cut into small slices (one slice per share on issue). now with the second listing its like taking half the cake to your mother in laws house before cutting it up. so now you have half a cake to share amongst the asx share holders, and half a cake for the dual listing share holders. as the size of the cake (CPH) hasn't changed, each slice representing 1 share should now be half the size right? so shouldn't the share price retract to factor in the massive dilution?
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.